Back to NTLA

Intellia Therapeutics, Inc. 10-Q

Accession 0001564590-19-015384

Filing information

CIK
0001652130
Report date
2019-03-31
Filing date
2019-05-02
Form
10-Q
Primary document
ntla-10q_20190331.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.